Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement. - Wikidata - awgldk - TriplyDB

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

http://www.wikidata.org/entity/Q35883004

about

Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence γδ-T cells: an unpolished sword in human anti-infection immunity γδ T cell and other immune cells crosstalk in cellular immunity 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity The role of gamma delta T cells in haematopoietic stem cell transplantation γδ T Cells in HIV Disease: Past, Present, and Future Cord blood Vγ2Vδ2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity.Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.Targeting CD137 enhances the efficacy of cetuximab.Immunotherapy for the treatment of prostate cancer.Targeting γδ T cells for immunotherapy of HIV disease Plasticity of γδ T Cells: Impact on the Anti-Tumor Response CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.Bisphosphonates inactivate human EGFRs to exert antitumor actions.The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.HIV-1-induced impairment of dendritic cell cross talk with γδ T lymphocytes.Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.Stimulation of natural killer cells with a CD137-specific antibody enhances trastuzumab efficacy in xenotransplant models of breast cancer.Impact of persistent HIV replication on CD4 negative Vγ2Vδ2 T cells.Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation.Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production.Depletion and dysfunction of Vγ2Vδ2 T cells in HIV disease: mechanisms, impacts and therapeutic implications.Combination therapy with zoledronic acid and cetuximab effectively suppresses growth of colorectal cancer cells regardless of KRAS status.Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.Soypeptide lunasin in cytokine immunotherapy for lymphoma.Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma.Human γδT-cell subsets and their involvement in tumor immunity.Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.Searching for "signal 2": costimulation requirements of γδ T cells.Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.New perspectives on zoledronic acid in breast cancer: potential augmentation of anticancer immune response.Combination strategies to enhance antitumor ADCC.Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.Potential of human γδ T cells for immunotherapy of osteosarcoma.The TNF receptor-ligands 4-1BB-4-1BBL and GITR-GITRL in NK cell responses.Gammadelta T cells: innately adaptive immune cells?

P2860

Q26795493-BB9CC850-344E-4DB6-98D4-3A17A1F10527 Q26994963-37D04DB8-E139-4043-9465-A54BFC05FA00 Q27007775-81BCD4EF-1C10-49C9-8CFB-CCB298B44C17 Q27012963-9E2DD9B2-A81B-46DA-B5C5-96ACD725F2F2 Q27030355-8C59FA5B-EAFA-42AD-99C2-D92390212971 Q28084822-F03C4A93-34B2-4B65-AFEE-A26B7D550FD1 Q33554677-B817807F-2E86-4F11-ACD9-98268F80A5F9 Q33855566-CF022A83-416D-4293-9348-56F54971E09B Q33872482-B11D0CEF-8EBD-419C-8A68-64AEFF9F5782 Q34186928-C3F8BAB0-7E81-416C-A42B-1CDB5188D740 Q34585223-F2B4F695-937C-4F39-9AC4-FD06EB29002A Q34652408-C012FA5D-1929-43B8-B82A-FC5D232F4C92 Q34707604-DC0026F2-CE2A-454B-8ABE-E91BA340313E Q34752876-61EEB32F-5C6D-447B-A328-256D7300F6B7 Q35102332-A9227B4A-D151-45C8-8FD5-99342BBD187F Q35488947-667CC2EA-ED65-4C3A-B409-74A77280ED86 Q35655447-06745DF1-F3FD-4192-9FD2-9D26674285E1 Q35780315-2CB34746-6DF0-41BA-B680-3E6522C1F720 Q35883452-6AEF38B1-25CB-4A2C-87DB-D1486CA8B6FA Q36060352-EFC7617A-DD4F-40C5-ADAF-8938DC50F24D Q36204132-908287E2-AE24-41AD-9DAC-76B15462AC85 Q36232232-9369C63E-6390-4D8E-A4AC-7F6B0D368722 Q36803818-1275E701-500D-4971-BF98-B940C8C0AC99 Q36914497-F098D1D1-52F3-498D-B2DA-E5C61A2DFC92 Q37120215-4214C8B3-50BF-4C6B-A404-D874B663A483 Q37325930-833B512F-7F9A-4ABF-AC99-A40F313B9DA7 Q37535232-B3DF017C-883E-4C6B-9E74-4536EDE452A3 Q37592014-4D8214D4-A8F6-4A53-9620-744435F0EFC5 Q37609431-7BD80DB4-DC02-4137-8765-D15D67F70210 Q37701514-2DCA4460-3C0E-41AD-9104-F4973CFB8C17 Q37714642-1B4E7486-3188-405C-A979-43419EE64500 Q37729133-508D8CDA-CC20-4F48-BAC7-67AA0078E6AB Q37871903-EFA692B9-2ADB-43FD-9201-5E2CC136FE68 Q37876363-DE06DDE6-A303-4287-92C1-BECB9A3DFF0D Q37917774-62EAA2CB-14B5-4998-9EAB-512FAD327FA1 Q38014085-9589C2BE-E11C-4C10-AF3D-22ED03A81C78 Q38051730-0D347922-9505-4A77-AB2B-612E7288D418 Q38052064-97D9BC94-34A8-40B4-8DE8-2311A895F584 Q38073762-9C6ECFB8-429C-4D43-A9A9-7CA54D462098 Q38101588-0965B1C9-7F44-497B-B500-248F95383CFF

P2860

Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.

http://www.wikidata.org/entity/Q35883004

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@ast

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@en

type

label

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@ast

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@en

prefLabel

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@ast

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@en

P1433

Q35883004-D830FA80-D7A4-4944-A50D-5ED02CFD5606

P1476

Q35883004-649875F6-626D-4259-AA22-9C8688943447

P2093

Q35883004-08054E80-5C33-4918-BC0A-5556A46C0848

Q35883004-3D0DFA9A-6899-4885-B6A3-E77C93AE0134

Q35883004-5392C6C0-1494-4531-943E-196691C467C3

Q35883004-5BB66189-4BB6-42D6-801A-7CFEEA1A128C

Q35883004-72840767-0D9A-4DC9-A863-8338B5B727F2

Q35883004-78B09A54-5503-4577-8D38-C31121490001

Q35883004-FE5FB2EF-475D-4D5A-9956-AF4BF15B7273

P2860

Q35883004-0DDC5CAE-EF5B-416D-B1DD-7906E7D69E3C

Q35883004-0FCAE1BA-D83B-4D6C-9465-B716C203DF22

Q35883004-14A0F270-0CC1-4307-A726-7D98D702E5A6

Q35883004-17175A58-8D6A-4FF6-8CBF-E5C576CCA33C

Q35883004-1B66D3A8-1D1F-4BC7-919F-50AEB34EEE8B

Q35883004-27D4513C-4DD6-4339-BCEF-91D9CB8462BA

Q35883004-5FAD39CE-7831-4FAA-9B70-5CBECD8F7B02

Q35883004-634F753F-91A3-403A-A6AC-6CD7E545176B

Q35883004-63629C43-6831-41A3-A5D8-7C808EE64761

Q35883004-6398E8E2-055C-41B5-83DF-4D60B7EB3F26

P304

Q35883004-CE1EA184-8CF5-4539-87B1-D83B8981D879

P31

Q35883004-073EA8CD-1CB6-4200-BAB3-003AB3EC2701

P356

Q35883004-9D434C98-F777-4F61-94E9-B3A723BF373F

P407

Q35883004-DFEAC47B-4DA3-4E20-8CE2-0F1D2FEDB861

P433

Q35883004-444BDB09-8B7C-4785-B719-C7305F2C2E3C

P478

Q35883004-38E9E439-37BB-4A38-A8F1-F53DB5CEC2C7

P577

Q35883004-666CCE04-87F9-447E-97D6-631C460ECB25

P5875

Q35883004-AC82B013-E232-4A9E-92C9-9C24924EF0F3

P698

Q35883004-20CC07D7-976D-4D41-B169-42031A16C634

P921

Q35883004-B7827DFC-1E42-4CE4-ADBF-41B673A89C15

P932

Q35883004-67337E42-5923-4F44-B27D-B8D80AEF5D7C

P356

BLOOD-2009-07-234211

P1433

P1476

Human gammadelta T lymphocytes ...... city through CD137 engagement.

@en

P2093

Amudhan Maniar

http://www.w3.org/2001/XMLSchema#string

Andrei I Chapoval

http://www.w3.org/2001/XMLSchema#string

Brian R Gastman

http://www.w3.org/2001/XMLSchema#string

C David Pauza

http://www.w3.org/2001/XMLSchema#string

Scott E Strome

http://www.w3.org/2001/XMLSchema#string

Wei Lin

http://www.w3.org/2001/XMLSchema#string

Xiaoyu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

NK cell recognition

Natural killer cells, viruses and cancer.

Individual Vgamma2-Jgamma1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens.

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

V gamma 9V delta 2 T cell response to colon carcinoma cells.

The new B7s: playing a pivotal role in tumor immunity.

Control of natural killer cell-mediated innate resistance against the intracellular pathogen Listeria monocytogenes by gamma/delta T lymphocytes.

P304

1726-1733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-07-234211

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44646213

http://www.w3.org/2001/XMLSchema#string

P698

20519625

http://www.w3.org/2001/XMLSchema#string

P921

P932

3324253

http://www.w3.org/2001/XMLSchema#string